Latest Insider Transactions at Marinus Pharmaceuticals, Inc. (MRNS)
This section provides a real-time view of insider transactions for Marinus Pharmaceuticals, Inc. (MRNS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of MARINUS PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of MARINUS PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 18
2024
|
Elan Ezickson Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,600
+31.08%
|
-
|
|
Jan 18
2024
|
Christine Berni Silverstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,600
+28.05%
|
-
|
|
Jan 18
2024
|
Marvin Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,600
+28.05%
|
-
|
|
Jan 18
2024
|
Sarah B. Noonberg |
BUY
Grant, award, or other acquisition
|
Direct |
4,600
+28.05%
|
-
|
|
Jan 18
2024
|
Steven Pfanstiel CFO AND COO |
BUY
Grant, award, or other acquisition
|
Direct |
25,465
+25.4%
|
-
|
|
Jan 18
2024
|
Joseph Hulihan CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
21,835
+23.92%
|
-
|
|
Jan 18
2024
|
Martha E Manning SVP, GEN. COUNSEL & CORP. SEC. |
BUY
Grant, award, or other acquisition
|
Direct |
21,835
+28.47%
|
-
|
|
Jan 18
2024
|
Christina Shafer CHIEF COMMERCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
21,835
+25.9%
|
-
|
|
Jan 18
2024
|
Timothy M Mayleben Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,600
+17.24%
|
-
|
|
Jan 18
2024
|
Charles Austin |
BUY
Grant, award, or other acquisition
|
Direct |
4,600
+31.77%
|
-
|
|
Jan 18
2024
|
Sara Nochur |
BUY
Grant, award, or other acquisition
|
Direct |
4,600
+29.58%
|
-
|
|
Jan 18
2024
|
Scott Braunstein CHAIRMAN AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
74,600
+24.07%
|
-
|
|
Aug 08
2023
|
Joseph Hulihan CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
13
-0.03%
|
$104
$8.93 P/Share
|
|
Aug 08
2023
|
Martha E Manning SVP, GEN. COUNSEL & CORP. SEC. |
SELL
Open market or private sale
|
Direct |
11
-0.03%
|
$88
$8.93 P/Share
|
|
Aug 08
2023
|
Steven Pfanstiel CFO AND COO |
SELL
Open market or private sale
|
Direct |
14
-0.03%
|
$112
$8.93 P/Share
|
|
Aug 08
2023
|
Scott Braunstein CHAIRMAN AND CEO |
SELL
Open market or private sale
|
Direct |
30
-0.02%
|
$240
$8.94 P/Share
|
|
Aug 08
2023
|
Christina Shafer CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
11
-0.03%
|
$88
$8.93 P/Share
|
|
Aug 07
2023
|
Joseph Hulihan CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,889
-5.72%
|
$26,001
$9.55 P/Share
|
|
Aug 07
2023
|
Martha E Manning SVP, GEN. COUNSEL & CORP. SEC. |
SELL
Open market or private sale
|
Direct |
2,169
-6.16%
|
$19,521
$9.54 P/Share
|
|
Aug 07
2023
|
Steven Pfanstiel CFO AND COO |
SELL
Open market or private sale
|
Direct |
2,790
-5.35%
|
$25,110
$9.54 P/Share
|
|
Aug 07
2023
|
Scott Braunstein CHAIRMAN AND CEO |
SELL
Open market or private sale
|
Direct |
6,413
-3.84%
|
$57,717
$9.55 P/Share
|
|
Aug 07
2023
|
Christina Shafer CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,385
-5.54%
|
$21,465
$9.52 P/Share
|
|
May 16
2023
|
Sarah B. Noonberg |
BUY
Grant, award, or other acquisition
|
Direct |
7,200
+50.0%
|
-
|
|
Apr 17
2023
|
Marvin Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,200
+50.0%
|
-
|
|
Feb 06
2023
|
Charles Austin |
SELL
Open market or private sale
|
Direct |
1,073
-16.9%
|
$6,438
$6.49 P/Share
|
|
Feb 06
2023
|
Elan Ezickson Director |
SELL
Open market or private sale
|
Direct |
750
-11.81%
|
$4,500
$6.56 P/Share
|
|
Feb 06
2023
|
Seth H. Z. Fischer Director |
SELL
Open market or private sale
|
Direct |
1,018
-14.45%
|
$6,108
$6.54 P/Share
|
|
Jan 26
2023
|
Scott Braunstein CHAIRMAN AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
80,000
+32.36%
|
-
|
|
Jan 26
2023
|
Joseph Hulihan CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
25,648
+33.67%
|
-
|
|
Jan 26
2023
|
Christina Shafer CHIEF COMMERCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
17,375
+28.77%
|
-
|
|
Jan 26
2023
|
Steven Pfanstiel CFO AND COO |
BUY
Grant, award, or other acquisition
|
Direct |
28,130
+35.05%
|
-
|
|
Jan 26
2023
|
Seth H. Z. Fischer Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,600
+33.82%
|
-
|
|
Jan 26
2023
|
Elan Ezickson Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,600
+36.18%
|
-
|
|
Jan 26
2023
|
Martha E Manning SVP, GEN. COUNSEL & CORP. SEC. |
BUY
Grant, award, or other acquisition
|
Direct |
16,548
+31.98%
|
-
|
|
Jan 26
2023
|
Sara Nochur |
BUY
Grant, award, or other acquisition
|
Direct |
3,600
+36.18%
|
-
|
|
Jan 26
2023
|
Timothy M Mayleben Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,600
+17.08%
|
-
|
|
Jan 26
2023
|
Christine Berni Silverstein Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,200
+50.0%
|
-
|
|
Jan 26
2023
|
Charles Austin |
BUY
Grant, award, or other acquisition
|
Direct |
3,600
+36.18%
|
-
|
|
Nov 09
2022
|
Christina Shafer CHIEF COMMERCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
1,505
-5.54%
|
$6,020
$4.7 P/Share
|
|
May 24
2022
|
Steven Pfanstiel CFO AND COO |
BUY
Grant, award, or other acquisition
|
Direct |
7,448
+23.69%
|
-
|
|
May 24
2022
|
Scott Braunstein CHAIRMAN AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
19,305
+18.13%
|
-
|
|
May 24
2022
|
Joseph Hulihan CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
7,718
+23.69%
|
-
|
|
May 24
2022
|
Martha E Manning SVP, GEN. COUNSEL & CORP. SEC. |
BUY
Grant, award, or other acquisition
|
Direct |
5,790
+23.68%
|
-
|
|
Feb 04
2022
|
Santiago Arroyo Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,750
+50.0%
|
-
|
|
Feb 04
2022
|
Charles Austin |
BUY
Grant, award, or other acquisition
|
Direct |
2,750
+50.0%
|
-
|
|
Feb 04
2022
|
Scott Braunstein CHAIRMAN AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
42,900
+38.72%
|
-
|
|
Feb 04
2022
|
Michael R Dougherty Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,750
+45.36%
|
-
|
|
Feb 04
2022
|
Elan Ezickson Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,750
+50.0%
|
-
|
|
Feb 04
2022
|
Seth H. Z. Fischer Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,750
+44.4%
|
-
|
|
Feb 04
2022
|
Joseph Hulihan CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
17,150
+50.0%
|
-
|